Medical News

---

• Neutrophil gelatinase-associated lipocalin increased in COPD
• Early cannabis use linked to increased subclinical psychotic symptoms
• Bipolar patients encouraged to use weight counseling services
• New drug shows promise for HER2-positive metastatic breast cancer
• Low-risk prostate cancer patients undergo unnecessary imaging
• Rising metabolic syndrome prevalence is serious US public health concern
• Nonfasting triglycerides ‘offer no extra information on CVD risk’
• Fatty acid metabolism plays role in Type 2 diabetes etiology
• Arterial stiffening could predict CVD risk in Type 2 diabetes
• End-of-life costs for HF patients ‘spiraling upwards’
• Trial results support restrictive approach to peri-operative blood transfusion

Neutrophil gelatinase-associated lipocalin increased in COPD Posted: 13 Oct 2010 05:00 PM PDT Plasma levels of neutrophil gelatinase-associated lipocalin are increased in patients with chronic obstructive pulmonary disease, and could serve as a marker for the respiratory condition, say researchers.

Early cannabis use linked to increased subclinical psychotic symptoms Posted: 13 Oct 2010 05:00 PM PDT Individuals who start using cannabis at the age of 12 years or younger experience more subclinical psychotic symptoms than those who start using the drug in later adolescence, research suggests.

Bipolar patients encouraged to use weight counseling services Posted: 13 Oct 2010 05:00 PM PDT Results from a US study suggest that greater efforts are needed to encourage the continued use of weight counseling services among bipolar disorder patients.

New drug shows promise for HER2-positive metastatic breast cancer Posted: 12 Oct 2010 05:00 PM PDT A new type of targeted therapy for breast cancer has shown encouraging results in patients with human epidermal growth factor receptor 2-positive metastatic disease, researchers report.

Low-risk prostate cancer patients undergo unnecessary imaging Posted: 12 Oct 2010 05:00 PM PDT Many urologists continue to refer low-risk prostate cancer patients for imaging to stage their disease before treatment, against the advice of international guidelines, show the results of a US study.

Rising metabolic syndrome prevalence is serious US public health concern Posted: 12 Oct 2010 05:00 PM PDT The number of US adults with the metabolic syndrome is increasing, a study shows, raising concerns about the associated risk for a concomitant increase in Type 2 diabetes.

Nonfasting triglycerides ‘offer no extra information on CVD risk’ Posted: 12 Oct 2010 05:00 PM PDT Blood levels of nonfasting triglycerides are associated with the risk for cardiovascular disease mortality in men, but the link offers no predictive information beyond standard risk factors, a Norwegian study suggests.

Fatty acid metabolism plays role in Type 2 diabetes etiology Posted: 12 Oct 2010 05:00 PM PDT Patients with Type 2 diabetes have an altered fatty acid pattern compared with individuals with normal glucose tolerance, research shows.

Arterial stiffening could predict CVD risk in Type 2 diabetes Posted: 12 Oct 2010 05:00 PM PDT Patients with Type 2 diabetes show stiffening of the large central arteries, a finding that is closely associated with diastolic dysfunction, report researchers who suggest that these disorders have a common etiology.

End-of-life costs for HF patients ‘spiraling upwards’ Posted: 12 Oct 2010 05:00 PM PDT End-of-life costs for patients with heart failure are increasing in Canada and the USA, despite a shift from inpatient to outpatient care, two studies reveal.

Trial results support restrictive approach to peri-operative blood transfusion Posted: 12 Oct 2010 05:00 PM PDT Restricting the use of red blood cell transfusions in patients undergoing elective cardiac surgery does not increase peri-operative risk, the results of a randomized controlled trial suggest.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610